Iveric Bio Inc (ISEE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ISEE Annual Balance Sheets →
Balance sheet data covering Iveric Bio Inc–Mar 31 2022 offers a view into how Mar 31 2023's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2023)
(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Assets
Cash & cash equivalent467.57
Available-for-sale Securities, Debt Securities MA132.35
Cash & Short-term Investments599.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current11.62
Total Current Assets611.54
Equipment/Property/Plant Net1.11
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset0.76
Total Assets613.41
Liabilities
Accounts Payable and Accrued Liabilities, Current LI18.03
Other Liabilities, Current21.35
Total Current Liabilities39.37
Long-term debt96.99
Total Long-term Debt96.99
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent0.00
Operating Lease Liability Current0.77
Total Liabilities136.36
Stockholders' Equity
Common Stock Value0.14
Additional Paid In Capital Common Stock1,414.04
Retained Earnings / Accumulated Deficit-937.04
Other Equity-0.10
Common Stockholder's Equity477.05
Total Stockholder's Equity477.05
Liabilities & Stockholder's Equity613.41
4 historic quarters locked

Sign in to unlock the full Iveric Bio Inc balance sheet history.

About Iveric Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001410939-23-000064

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.